In the following Journal for Clinical Studies article, Worldwide’s Dr. Michael Murphy, Chief Medical and Scientific Officer, and Barbara Zupancic, Senior Director of Patient Recruitment and Retention, discuss the elements of a patient-centric trial design, in addition to high-quality patient engagement and its impact on orphan drug success.
How Engaging Patients in Trial Design Maximizes Orphan Drug Success
Implementing the patient's voice in clinical trials
Read more